Targeted polylysine dendrimer therapeutic agent
US8420067B2 · kind B2 · utility
1Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2007 |
| Grant date | Apr 16, 2013 |
| Priority date | — |
| Expiry date | Aug 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to branched macromolecules bearing functional moieties. In particular, the invention relates to dendrimers, derived from lysine or lysine analogues, bearing a plurality of functional moieties. The invention further relates to the use of such macromolecules, particularly in therapeutic applications, and compositions comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.